ipsapirone has been researched along with Agoraphobia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bandelow, B; Bartmann, U; Broocks, A; George, A; Hillmer-Vogel, U; Meyer, T; Opitz, M; Pekrun, G; RĂ¼ther, E; Wedekind, D | 1 |
Bandelow, B; Bartmann, U; Broocks, A; Hajak, G; Hohagen, F; Kinkelbur, J; Koch, K; Schweiger, U | 1 |
2 trial(s) available for ipsapirone and Agoraphobia
Article | Year |
---|---|
5-HT1A responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placebo.
Topics: Adolescent; Adult; Agoraphobia; Body Temperature; Clomipramine; Combined Modality Therapy; Double-Blind Method; Exercise; Exercise Test; Exercise Therapy; Female; Humans; Hydrocortisone; Male; Middle Aged; Panic Disorder; Psychiatric Status Rating Scales; Pyrimidines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists | 2003 |
Smoking modulates neuroendocrine responses to ipsapirone in patients with panic disorder.
Topics: Adult; Agoraphobia; Behavior; Body Temperature; Brain; Drug Interactions; Female; Humans; Hydrocortisone; Male; Neurosecretory Systems; Nicotine; Panic Disorder; Pyrimidines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Receptor Agonists; Smoking; Synapses; Up-Regulation | 2002 |